Real-time enrollment status for this pulmonary disease, chronic obstructive clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 10:51 AM UTC
| NCT Number | NCT07177339 |
| Recruiting Status | Recruiting |
| Condition | Pulmonary Disease, Chronic Obstructive |
| Phase | PHASE3 |
| Target Enrollment | 1,196 participants |
| Active Locations | 1 sites in the US |
| Sponsor | GlaxoSmithKline |
| Last Updated on CT.gov | November 25, 2025 (Nov 25, 2025) |
As of July 20, 2026: Clinical trial NCT07177339 is currently recruiting participants. This phase3 study for pulmonary disease, chronic obstructive is actively seeking new participants at 1 location across the United States. The study is sponsored by GlaxoSmithKline. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07177339 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07177339 was last updated Nov 25, 2025 (November 25, 2025). HelloStudys verifies this status automatically.